Tags

Type your tag names separated by a space and hit enter

Should we dismiss fibrates for the treatment of diabetic dyslipidaemia?
Nutr Metab Cardiovasc Dis 2006; 16(8):509-12NM

Links

  • Publisher Full Text

    • Authors

    Taskinen MR
    No affiliation info available

    MeSH

    Cholesterol, HDLCoronary DiseaseDiabetes Mellitus, Type 2DyslipidemiasFemaleFenofibrateHumansHypolipidemic AgentsMaleRandomized Controlled Trials as Topic

    Pub Type(s)

    Editorial

    Language

    eng

    PubMed ID

    17071064

    Citation

    Taskinen, Marja-Riitta. "Should We Dismiss Fibrates for the Treatment of Diabetic Dyslipidaemia?" Nutrition, Metabolism, and Cardiovascular Diseases : NMCD, vol. 16, no. 8, 2006, pp. 509-12.
    Taskinen MR. Should we dismiss fibrates for the treatment of diabetic dyslipidaemia? Nutr Metab Cardiovasc Dis. 2006;16(8):509-12.
    Taskinen, M. R. (2006). Should we dismiss fibrates for the treatment of diabetic dyslipidaemia? Nutrition, Metabolism, and Cardiovascular Diseases : NMCD, 16(8), pp. 509-12.
    Taskinen MR. Should We Dismiss Fibrates for the Treatment of Diabetic Dyslipidaemia. Nutr Metab Cardiovasc Dis. 2006;16(8):509-12. PubMed PMID: 17071064.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Should we dismiss fibrates for the treatment of diabetic dyslipidaemia? A1 - Taskinen,Marja-Riitta, Y1 - 2006/10/30/ PY - 2006/08/03/received PY - 2006/08/08/accepted PY - 2006/10/31/pubmed PY - 2006/12/23/medline PY - 2006/10/31/entrez SP - 509 EP - 12 JF - Nutrition, metabolism, and cardiovascular diseases : NMCD JO - Nutr Metab Cardiovasc Dis VL - 16 IS - 8 SN - 1590-3729 UR - https://www.unboundmedicine.com/medline/citation/17071064/Should_we_dismiss_fibrates_for_the_treatment_of_diabetic_dyslipidaemia L2 - https://linkinghub.elsevier.com/retrieve/pii/S0939-4753(06)00170-0 DB - PRIME DP - Unbound Medicine ER -